Bell JC - Search Results

1

Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibition.

Selman M, Ou P, Rousso C, Bergeron A, Krishnan R, Pikor L, Chen A, Keller BA, Ilkow C, Bell JC, Diallo JS. Selman M, et al. Among authors: bell jc. Sci Transl Med. 2018 Jan 24;10(425):eaao1613. doi: 10.1126/scitranslmed.aao1613. Sci Transl Med. 2018. PMID: 29367345

2

Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas.

Lun X, Yang W, Alain T, Shi ZQ, Muzik H, Barrett JW, McFadden G, Bell J, Hamilton MG, Senger DL, Forsyth PA. Lun X, et al. Cancer Res. 2005 Nov 1;65(21):9982-9990. doi: 10.1158/0008-5472.CAN-05-1201. Cancer Res. 2005. PMID: 16267023 Free PMC article.

3

Recent progress in the battle between oncolytic viruses and tumours.

Parato KA, Senger D, Forsyth PA, Bell JC. Parato KA, et al. Among authors: bell jc. Nat Rev Cancer. 2005 Dec;5(12):965-76. doi: 10.1038/nrc1750. Nat Rev Cancer. 2005. PMID: 16294217 Review.

4

Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity.

Power AT, Wang J, Falls TJ, Paterson JM, Parato KA, Lichty BD, Stojdl DF, Forsyth PA, Atkins H, Bell JC. Power AT, et al. Among authors: bell jc. Mol Ther. 2007 Jan;15(1):123-30. doi: 10.1038/sj.mt.6300039. Mol Ther. 2007. PMID: 17164783 Free article.

5

Oncolytic viruses: what's next?

Bell JC. Bell JC. Curr Cancer Drug Targets. 2007 Mar;7(2):127-31. doi: 10.2174/156800907780058844. Curr Cancer Drug Targets. 2007. PMID: 17346103 Review.

6

Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow.

Breitbach CJ, Paterson JM, Lemay CG, Falls TJ, McGuire A, Parato KA, Stojdl DF, Daneshmand M, Speth K, Kirn D, McCart JA, Atkins H, Bell JC. Breitbach CJ, et al. Among authors: bell jc. Mol Ther. 2007 Sep;15(9):1686-93. doi: 10.1038/sj.mt.6300215. Epub 2007 Jun 19. Mol Ther. 2007. PMID: 17579581 Free article.

7

Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin.

Lun XQ, Zhou H, Alain T, Sun B, Wang L, Barrett JW, Stanford MM, McFadden G, Bell J, Senger DL, Forsyth PA. Lun XQ, et al. Cancer Res. 2007 Sep 15;67(18):8818-27. doi: 10.1158/0008-5472.CAN-07-1214. Cancer Res. 2007. PMID: 17875723 Free PMC article.

8

Innate immunity, tumor microenvironment and oncolytic virus therapy: friends or foes?

Stanford MM, Breitbach CJ, Bell JC, McFadden G. Stanford MM, et al. Among authors: bell jc. Curr Opin Mol Ther. 2008 Feb;10(1):32-7. Curr Opin Mol Ther. 2008. PMID: 18228179 Review.

9

Taming the Trojan horse: optimizing dynamic carrier cell/oncolytic virus systems for cancer biotherapy.

Power AT, Bell JC. Power AT, et al. Among authors: bell jc. Gene Ther. 2008 May;15(10):772-9. doi: 10.1038/gt.2008.40. Epub 2008 Mar 27. Gene Ther. 2008. PMID: 18369325 Review.

10

Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis.

Nguyên TL, Abdelbary H, Arguello M, Breitbach C, Leveille S, Diallo JS, Yasmeen A, Bismar TA, Kirn D, Falls T, Snoulten VE, Vanderhyden BC, Werier J, Atkins H, Vähä-Koskela MJ, Stojdl DF, Bell JC, Hiscott J. Nguyên TL, et al. Among authors: bell jc. Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):14981-6. doi: 10.1073/pnas.0803988105. Epub 2008 Sep 24. Proc Natl Acad Sci U S A. 2008. PMID: 18815361 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters